Publication Cover
Physiotherapy Theory and Practice
An International Journal of Physical Therapy
Volume 39, 2023 - Issue 3
284
Views
0
CrossRef citations to date
0
Altmetric
Descriptive Report

Validation of Turkish version of the Cochin 17-item Scleroderma Functional scale

, MSc, PTORCID Icon, , PhD, PTORCID Icon, , PhD, MDORCID Icon & , PhD, MDORCID Icon
Pages 576-581 | Received 02 Feb 2021, Accepted 17 Nov 2021, Published online: 02 Jan 2022

References

  • Beaton DE, Bombardier C, Guillemin F, Ferraz MB 2000 Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24): 3186–3191. doi:10.1097/00007632-200012150-00014
  • Bland JM, Altman DG 1997 Cronbach’s alpha. British Medical Journal 314(7080): 572. doi:10.1136/bmj.314.7080.572
  • Choi MY, Fritzler MJ 2016 Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis. Current Opinion in Rheumatology 28(6): 586–594. doi:10.1097/BOR.0000000000000325
  • Clements PJ 2000 Systemic sclerosis (scleroderma) and related disorders: Clinical aspects. Best Practice and Research: Clinical Rheumatology 14(1): 1–16. doi:10.1053/berh.1999.0074
  • Crincoli V, Fatone L, Fanelli M, Rotolo RP, Chiala A, Favia G, Lapadula G 2016 Orofacial manifestations and temporomandibular disorders of systemic scleroderma: An observational study. International Journal of Molecular Sciences 17(7): 1189. doi:10.3390/ijms17071189
  • Daste C, Abdoul H, Foissac F, Papelard A, Alami S, Kwakkenbos L, Carrier ME, Lefevre-Colau MM, Thombs BD, Poiraudeau S, et al. 2020 Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: The Cochin 17‐item scleroderma functional scale. British Journal of Dermatology 183(4): 710–718. doi:10.1111/bjd.18922
  • Daste C, Rannou F, Mouthon L, Sanchez K, Roren A, Tiffreau V, Hachulla E, Thoumie P, Cabane J, Chatelus E, et al. 2019 Patient acceptable symptom state and minimal clinically important difference for patient reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care. Seminars in Arthritis and Rheumatism 48: 694–700. doi: 10.1016/j.semarthrit.2018.03.013
  • Deyo RA, Diehr P, Patrick DL 1991 Reproducibility and responsiveness of health status measures statistics and strategies for evaluation. Controlled Clinical Trials 12(4): 142–158. doi:10.1016/S0197-2456(05)80019-4
  • Duckworth AL, Kern ML 2011 A meta-analysis of the convergent validity of self-control measures. Journal of Research in Personality 45(3): 259–268. doi:10.1016/j.jrp.2011.02.004
  • Feise RJ, Menke JM 2001 Functional rating index: A new valid and reliable instrument to measure the magnitude of clinical change in spinal conditions. Spine 26(1): 78–87. doi:10.1097/00007632-200101010-00015
  • Herdman M, Fox-Rushby J, Badia X 1998 A model of equivalence in the cultural adaptation of HRQoL instruments: The universalist approach. Quality of Life Research 7(4): 323–335. doi:10.1023/A:1008846618880
  • Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF 2003 A comparison of two time intervals for test-retest reliability of health status instruments. Journal of Clinical Epidemiology 56(8): 730–735. doi:10.1016/S0895-4356(03)00084-2
  • Merkel PA, Clements PJ, Reveille JD, Suarez-Almazor ME, Valentini G, Furst DE 2003 Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. Journal of Rheumatology 30: 1630–1647
  • Paik JJ, Wigley FM, Mejia AF, Hummers LK 2016 Independent association of severity of muscle weakness with disability as measured by the health assessment questionnaire disability index in scleroderma. Arthritis Care and Research 68:1695–1703. doi:10.1002/acr.22870
  • Papelard A, Daste C, Alami S, Sanchez K, Roren A, Segretin F, Lefevre-Colau MM, Rannou F, Mouthon L, Poiraudeau S, et al. 2019 Construction of an ICF core set and ICF-based questionnaire assessing activities and participation in patients with systemic sclerosis. Rheumatology 58: 2260–2272. doi: 10.1093/rheumatology/kez209
  • Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE 2015 Pathogenesis of systemic sclerosis. Frontiers in Immunology 6:272. doi:10.3389/fimmu.2015.00272
  • Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J, Guillevin L, Revel M, Fermanian J, Mouthon L 2007 Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin hand function scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey. Arthritis and Rheumatology 57(1): 94–102. doi:10.1002/art.22468
  • Saketkoo LA, Escorpizo R, Keen KJ, Fligelstone K, Distler O 2012 International classification of functioning, disability and health core set construction in systemic sclerosis and other rheumatic diseases: A EUSTAR initiative. Rheumatology 51(12): 2170–2176. doi:10.1093/rheumatology/kes185
  • Steen VD, Medsger TA 1997 The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis and Rheumatology 40(11): 1984–1991. doi:10.1002/art.1780401110
  • Terwee CB, Bot SD, de Boer M, van der Windt D, Knol DL, Dekker J, Bouter LM, de Vet H 2007 Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology 60:34–42. doi:10.1016/j.jclinepi.2006.03.012
  • Ware JP, Kosinski M, Keller SD 1996 A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care 34:220–233. doi:10.1097/00005650-199603000-00003
  • Weir JP 2005 Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. Journal of Strength and Conditioning Research 19:231–240. doi:10.1519/15184.1
  • White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, Lachenbruch PA, Leroy EC, Mitrane MP, Paulus HE, et al. 1995 Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. Arthritis and Rheumatology 38(3): 351–630. doi:10.1002/art.1780380309
  • Zigmond A, Snaith R 1983 The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67(6): 361–370. doi:10.1111/j.1600-0447.1983.tb09716.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.